Discontinuation report CIPRO XL
Report ID | 153198 |
Drug Identification Number | 02247916 |
Brand name | CIPRO XL |
Common or Proper name | CIPROFLOXACIN |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 500MG |
Dosage form(s) | TABLET (IMMEDIATE AND EXTENDED RELEASE) TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 50'S |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-01-31 |
Actual discontinuation date | 2022-03-01 |
Remaining supply date | 2022-01-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-01-20 | English | Compare |
v2 | 2022-01-20 | French | Compare |
v3 | 2022-03-02 | English | Compare |
v4 | 2022-03-02 | French | Compare |
Showing 1 to 4 of 4